Skip Navigation

The Lesser Evil of E-Cigarettes (Scientific American)

Article by CAAT Director Thomas Hartung. 

Excerpt:

No one disputes the fact that cigarette smoking kills, although many people might not realize just how lethal it really is. The World Health Organization estimates that tobacco kills up to one half of its regular users via cardiovascular disease, lung and other cancers, and respiratory illnesses. About 30 percent of current U.S. cancer deaths result from tobacco use.

Electronic cigarettes, however, are taking over at an astonishing pace. They were introduced in the early 2000s, and according to some experts, sales could exceed those of traditional tobacco products within a few years. In reaction, the U.S. Food and Drug Administration announced in May that it would ban sales to individuals younger than 18; it would also require manufacturers to register their products with the agency and submit ingredients for safety testing. Some countries, such as New Zealand, ban e-cigarettes that contain nicotine entirely.

Policies that restrict e-smoking are reasonable. We don't know yet what kind of health risks it carries, so we don't want people who don't smoke—especially kids—to take it up. And yet we should keep in mind that such vaping is almost certainly safer than conventional smoking: some experts have suggested that e-cigarettes carry only between 3 and 5 percent of the health risks of tobacco smoking. We don't want to ban vaping or make it too hard to do, because if smokers can't quit, they should switch to the less harmful habit.

Full Article at Scientific American

New ALTEX: 2/2018

ALTEX cover 51
 

Support ALTWEB, Make a Gift
Online Humane Science Course

MeetingS

 
Building a Better Epithelium: New Frontiers in 3D Conference
April 25, 2019
Cambridge, MA

CellTox 2019
May 7, 2019
Milano, Italy

Biosystems Engineering: Bioreactors and Cell Factories
May 12-17, 2019
Braunweld, Switzerland

ALTERTOX Academy Training:
In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhalation Toxicology
May 23-24, 2019
Neuchatel, Switzerland

6th Symposium on Social Housing of Laboratory Animals
June 3-4, 2019
Beltsville, Maryland

Society for In Vitro Biology Annual Meeting
June 8-12, 2019
Tampa, Florida

Upcoming: CAAT-Europe Information Day On Biology-inspired Microphysiological Systems (MPS) to Advance Medicines for Patients' Benefit
June 17, 2019
Berlin, Germany

ALTERTOX Academy Training:
PBPK Modeling and Quantitative In Vitro-In Vivo Extrapolation
October 3-4, 2019
Wageningen, Netherlands

ALTERTOX Academy Training:
Novel In Silico Models for Assessment of Cosmetics
October 17-18, 2019
Milan, Italy

ALTERTOX Academy Training:
In Vitro Lung Models
November 14-15, 2019
Geneva, Switzerland

Save the Date!
5th International Conference on Alternatives for Developmental Neurotoxicity (DNT) Testing
February 3-5, 2020
Konstanz, Germany

Full Listing of CAAT Programs
and Activities